CORRESP Filing
OneMedNet Corp
Date: July 11, 2025 · CIK: 0001849380 · Accession: 0001641172-25-018840
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276130
Letter
VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services Attention: Kat Bagley and Robert Augustin Re: OneMedNet Corporation Amendment No. 4 to Registration Statement on Form S-1 Filed June 25, 2025 File No. 333-276130
Dear Ms. Bagley and Mr. Augustin:
In response to your oral comment delivered by telephone to the Company's counsel on July 8, 2025 (the "Oral Comment"), OneMedNet Corporation (the "Company") hereby submits this response to the Oral Comment relating to the above-referenced Registration Statement on Form S-1 (the "Registration Statement"). For convenience, the Oral Comment is set forth herein, followed by our response. The Company has revised the Registration Statement in response to the Staff's comment and is filing concurrently with this letter an Amendment No. 5 to the Registration Statement (the "Amendment") that reflects these revisions and generally updates other information contained therein.
Amendment No. 4 to Registration Statement on Form S-1
General
1. We note your revised disclosure that you are registering for resale "250,000 shares of Common Stock to be issued to Slickage Studios LLC ("Slickage") pursuant to a letter agreement to settle certain debts owed by the Company to Slickage." Please revise the disclosure where appropriate to provide the material terms of the letter agreement between the Company and Slickage, and file the letter agreement or tell us why you are not required to do so. See Section 601(b)(10) of Regulation S-K.
Response: We respectfully acknowledge the Staff's comment, and the Amendment has been updated to provide the material terms of the letter agreement between the Company and Slickage. The letter agreement between the Company and Slickage has also been filed with the Amendment.
* * * *
Division of Corporation Finance
Office of Industrial Applications and Services
July 11, 2025
Page
If we can facilitate the Staff's review, or if the Staff has any questions on any of the information set forth herein, please telephone me at 800-918-7189. Thank you again for your time and consideration.
Respectfully
submitted,
By:
/s/
Aaron Green
Show Raw Text
CORRESP
1
filename1.htm
July
11, 2025
VIA
EDGAR
Division
of Corporation Finance
Office
of Industrial Applications and Services
U.S.
Securities and Exchange Commission
100
F Street, N.E.
Washington,
DC 20549
Attention:
Kat Bagley and Robert Augustin
Re:
OneMedNet
Corporation
Amendment
No. 4 to Registration Statement on Form S-1
Filed
June 25, 2025
File
No. 333-276130
Dear
Ms. Bagley and Mr. Augustin:
In
response to your oral comment delivered by telephone to the Company's counsel on July 8, 2025 (the "Oral Comment"),
OneMedNet Corporation (the "Company") hereby submits this response to the Oral Comment relating to the above-referenced Registration
Statement on Form S-1 (the "Registration Statement"). For convenience, the Oral Comment is set forth herein, followed by
our response. The Company has revised the Registration Statement in response to the Staff's comment and is filing concurrently
with this letter an Amendment No. 5 to the Registration Statement (the "Amendment") that reflects these revisions and generally
updates other information contained therein.
Amendment
No. 4 to Registration Statement on Form S-1
General
1. We
note your revised disclosure that you are registering for resale "250,000 shares of
Common Stock to be issued to Slickage Studios LLC ("Slickage") pursuant to a
letter agreement to settle certain debts owed by the Company to Slickage." Please revise
the disclosure where appropriate to provide the material terms of the letter agreement between
the Company and Slickage, and file the letter agreement or tell us why you are not required
to do so. See Section 601(b)(10) of Regulation S-K.
Response:
We respectfully acknowledge the Staff's comment, and the Amendment has been updated to provide the material terms of the letter
agreement between the Company and Slickage. The letter agreement between the Company and Slickage has also been filed with the Amendment.
*
* * *
Division
of Corporation Finance
Office
of Industrial Applications and Services
July
11, 2025
Page
2
If
we can facilitate the Staff's review, or if the Staff has any questions on any of the information set forth herein, please telephone
me at 800-918-7189. Thank you again for your time and consideration.
Respectfully
submitted,
By:
/s/
Aaron Green
Aaron
Green
Chief
Executive Officer
cc: Robert
Golden, Chief Financial Officer (OneMedNet Corporation)
Eitan
Hoenig, Perkins Coie LLP
Ned
Prusse, Perkins Coie LLP